NC State Awards 2019 Innovator & Entrepreneur of the Year
NC State strives to attract top-notch talent to our university. And the driven, dedicated people here consistently turn NC State research into real-world results, launching startups and patenting technologies at a record pace. In turn, NC State has continued to […]
Chancellor’s Innovation Fund Helps Turn NC State Research into Real-World Solutions
At NC State, we know discoveries made here can change the world. And this year, six promising projects will receive support from the Chancellor’s Innovation Fund (CIF), helping researchers turn their discoveries into market-ready solutions. “NC State continues to show […]
NIRSleep — a startup led by an NC State alumnus, former employee — wins $25,000 in 2019 Lulu eGames
Less than four years ago, Casey Boutwell was a licensing associate for the Office of Research Commercialization, helping NC State faculty take their research from the lab into the marketplace. Now, he’s the CEO of Bionica Labs, a holding company for two […]
NIRvana Sciences Awarded $3 Million Phase IIb SBIR Grant from NIH
NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins, today announced that it has been awarded a $3 Million Phase IIb SBIR grant from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of […]
NC State Spinout Locus Biosciences Inks Historic Licensing Deal
NC State provides innovators with a range of programs and services to develop, protect, market and commercialize inventions developed at the university through the licensing of intellectual property or the launch of new companies based on university innovations. An example […]
Howling Cow Ice Cream Available in Harris Teeter Stores
A State Fair and NC State campus delectable treat is now available for the first time in grocery retail locations across parts of the Triangle. Six different flavors of Howling Cow® ice cream can be purchased at 16 Harris Teeter locations […]
Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics
Locus Biosciences Inc., a biotechnology company developing precision antibacterial therapies, announced today that it has entered into an exclusive collaboration and license agreement with Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to develop, manufacture and commercialize CRISPR-Cas3-enhanced bacteriophage ("crPhage™") products targeting two key bacterial pathogens for the potential treatment of infections of the respiratory tract and other organ systems. Johnson & Johnson Innovation LLC facilitated the transaction.
Partner Profile: BRI Taps NC State Talent and Technology
Partnerships with NC State University’s research and academic programs have played a role in BioResource International’s success from the company’s start nearly 20 years ago – and they will in the future, as well.
Meet the 2019 Chancellor’s Innovation Fund Recipients
Groundbreaking research happens every day at NC State, and a growing number of important technologies are making the leap from lab to marketplace. It’s no surprise that adequate funding is crucial to this transition.
NCSU, UNC researchers develop drug-delivery system for rapid heart attack response
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug-delivery system that allows rapid response to heart attacks without surgical intervention. In laboratory and animal testing, the system proved to be […]